ESC Congress 2026 Abstract
LDL-C target achievement does not equal risk resolution after ACS: residual atherogenic and inflammatory burden despite maximal oral triple lipid therapy
Cohort study of 426 peopleInterventions
Papers on elevated Lp
122 papers37 new in 30 days